810130C

16:0-06:0 NBD PC

Avanti Research^™ - A Croda Brand 810130C

• 동의어(들): 1-palmitoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-phosphocholine
• 실험식(Hill 표기법): C₃₆H₆₂N₅O₁₁P
• CAS Number: 91992-01-7
• Molecular Weight: 771.88
• MDL number: MFCD00067469
• UNSPSC 코드: 12352211
• NACRES: NA.25

속성

• 분석: >99% (TLC)
• 양식: liquid
• 포장: pkg of 1 × 1 mL (810130C-1mg); pkg of 5 × 1 mL (810130C-5mg)
• 제조업체/상표: Avanti Research^™ - A Croda Brand 810130C
• 농도: 1 mg/mL (810130C-1mg); 1 mg/mL (810130C-5mg)
• 배송 상태: dry ice
• 저장 온도: −20°C

설명

일반 설명

Phosphocholine is considered as a precursor molecule. It is formed during the breakdown of phosphatidylcholine (PC) metabolism. 16:0-06:0 NBD PC is a fluorescent lipid.

애플리케이션

16:0-06:0 NBD PC I suitable for use:

• in the preparation of fluid phase fluorescent bilayers
• to prepare liposomes/small unilamellar vesicles (SUVs)
• as substrate in in vitro enzyme assay of lipoteichoic acid (LTA) synthase enzyme (LtaS) to determine the enzyme specificity

포장

5 mL Amber Glass Screw Cap Vial (810130C-1mg)

5 mL Amber Glass Screw Cap Vial (810130C-5mg)

법적 정보

Avanti Research is a trademark of Avanti Polar Lipids, LLC

안전성 정보

• 픽토그램: GHS06,GHS08
• 신호어: Danger
• 유해 및 위험 성명서: H302,H315,H319,H331,H336,H351,H361d,H372,H412
• 예방조치 성명서: P201 - P273 - P301 + P312 + P330 - P302 + P352 - P304 + P340 + P311 - P308 + P313
• Hazard Classifications: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• 표적 기관: Central nervous system, Liver,Kidney
• WGK: WGK 3